FEPUX | TIOVX | FEPUX / TIOVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 6 years | - |
Gain YTD | 7.372 | 5.616 | 131% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 134B | 2.45B | 5,463% |
Annual Yield % from dividends | 1.78 | 1.70 | 105% |
Returns for 1 year | 15.91 | 16.86 | 94% |
Returns for 3 years | -13.61 | -19.72 | 69% |
Returns for 5 years | N/A | 23.07 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WAMFX | 24.57 | 0.07 | +0.29% |
Boston Trust Walden Midcap | |||
BTEKX | 76.82 | -0.05 | -0.07% |
BlackRock Technology Opportunities K | |||
RYAVX | 80.80 | -0.11 | -0.14% |
Rydex S&P MidCap 400 Pure Value H | |||
ETAHX | 36.36 | -0.43 | -1.17% |
Eventide Healthcare & Life Sciences A | |||
TEMUX | 14.35 | -0.25 | -1.71% |
Morgan Stanley Pathway Em Mkts Eq |